Activist investor Ancora Holdings Group is urging Ashland Inc., a specialty materials company, to consider a competitive sale due to what it calls a "conglomerate discount" undervaluing the company. Ancora highlights Ashland's Life Sciences and Personal Care segments as key assets, representing 75-80% of EBITDA. Despite recent earnings misses causing a nearly 15% share price drop, UBS maintains a Buy rating and raised its price target to $72. Ancora plans to engage Ashland's board to explore a sale, estimating a potential price of $76.47 per share, supported by existing investor interest from Standard Industries.
SEALSQ and WISeKey announced progress on the Quantum Spatial Orbital Cloud (QSOC), a space-based platform delivering post-quantum cybersecurity, AI, and secure communications. The first QSOC satellite will launch with SpaceX in Q4 2026, starting a pl...
GraniteShares has announced weekly distributions for its YieldBOOST FoFs ETFs: YBST and YBTY. The YieldBOOST Top Yielders ETF (YBTY) offers a weekly distribution of $0.13521 per share with a distribution rate of 54.09%, while the YieldBOOST Single St...
Barrick Mining Corporation released its 2025 Sustainability Report highlighting a 60% reduction in injury rates since 2020 and a 28% drop in lost time injuries year-on-year, emphasizing its commitment to safety. The company also advanced its sustaina...
SpaceX is launching its IPO at $135 per share, valuing the company at about $1.75 trillion. Demand reportedly exceeds supply, leading 87% of Benzinga viewers to predict the stock will open above the IPO price. Investors are cautious about buying abov...
Marathon Petroleum's stock price neared its 52-week high following Morgan Stanley's price target raise to $265, reflecting strong analyst confidence. The company expects a 173.74% rise in earnings per share to $10.84, driven by robust refining margin...
